Cellular and immunologic mechanisms in atopic dermatitis.
about
The Potential of Plant Phenolics in Prevention and Therapy of Skin DisordersPolysaccharide extracted from Chinese white wax scale ameliorates 2,4-dinitrochlorobenzene-induced atopic dermatitis-like symptoms in BALB/c mice.Skin barrier functionAnti-inflammatory effects of Glehnia littoralis extract in acute and chronic cutaneous inflammation.Atopic dermatitis and fungi.7,8,4'-Trihydroxyisoflavone attenuates DNCB-induced atopic dermatitis-like symptoms in NC/Nga mice.Topical tacrolimus for the treatment of inflammatory skin diseases.New treatments for atopic dermatitis.Tacrolimus: a review of its use for the management of dermatoses.International Consensus Conference on Atopic Dermatitis II (ICCAD II): clinical update and current treatment strategies.Inhibitory Effect of Nelumbo nucifera (Gaertn.) on the Development of Atopic Dermatitis-Like Skin Lesions in NC/Nga Mice.Atopic dermatitis: an overview for the nurse practitioner.Basis for the barrier abnormality in atopic dermatitis: outside-inside-outside pathogenic mechanismsSolanum tuberosum L. cv Hongyoung extract inhibits 2,4‑dinitrochlorobenzene‑induced atopic dermatitis in NC/Nga mice.Immunosuppression of the trimellitic anhydride-induced th2 response by novel nonanatural products mixture in mice.Topical Application of Eupatilin Ameliorates Atopic Dermatitis-Like Skin Lesions in NC/Nga MicePathophysiology of allergic inflammation.Anti-IgE--emerging opportunities for Omalizumab.Assessment of atopic eczema: clinical scoring and noninvasive measurements.Mixture of Polyphenols and Anthocyanins from Vaccinium uliginosum L. Alleviates DNCB-Induced Atopic Dermatitis in NC/Nga Mice.Phase-dependent roles of E-selectin during chronic contact hypersensitivity responses.Effects of VitabridC12 on Skin Inflammation.Refractory pityriasis lichenoides chronica successfully treated with topical tacrolimus.Quality of life in children and teenagers with atopic dermatitis.Psychophysiological reactivity under mental stress in atopic dermatitis.Atopy patch test with Aleuroglyphus ovatus antigen in patients with atopic dermatitis.Cytokine gene polymorphisms in atopic dermatitis.Impaired responses of peripheral blood mononuclear cells to nickel in patients with nickel-allergic contact dermatitis and concomitant atopic dermatitis.A pilot study evaluating the clinical and immunomodulatory effects of an orally administered extract of Dendrobium huoshanense in children with moderate to severe recalcitrant atopic dermatitis.Circulating interleukin 16 (IL-16) in children with atopic/eczema dermatitis syndrome (AEDS): a novel serological marker of disease activity.Off-label use of omalizumab in non-asthma conditions: new opportunities.CTLA-4 expression in T cells of patients with atopic dermatitisTopical administration of EGF suppresses immune response and protects skin barrier in DNCB-induced atopic dermatitis in NC/Nga mice
P2860
Q26768462-7D42AE66-1975-4C3A-92DA-DA8E8BEECEF1Q33736050-7302A8E7-2154-4426-B90A-D9BB6A3FDA5EQ33744906-EA1E1783-90FC-4935-9D0B-FC3D8CECC700Q34021636-9E62AEAE-4635-48FF-B905-FA3D29F73EEDQ34102847-DE7C8A91-1A38-4E74-B04E-28E98861FAABQ34109984-C0CAB91D-3461-44DF-8ABB-1EBBF5068A6AQ34388615-7F6E6D0E-826E-45ED-925A-A402030E55FEQ34592295-7A56E351-B9B5-4D9C-952E-478E35B4C3E1Q34668921-9358DBB7-4285-4C02-8BEA-88F26AA83E76Q35106685-E8CBE65A-CDE9-40C9-8A19-CB00359B5304Q35793008-295512F3-D64D-404A-9C2A-B98890FD24CDQ35949489-42D75C91-FDBE-43BC-A70F-D7588D680B76Q37105441-BCCEA0D2-815B-46EC-8E2A-B57CC179D961Q37297547-C7DDD4D3-ED69-46BF-8FA6-5F8C87E30883Q37367040-E1989F0C-D959-4F7B-88EF-362393F41935Q37654057-65C369FB-5DF2-4284-8D08-77F682AFD90DQ37891126-E33EC303-7167-4B0D-BC3E-42B41F7B50F6Q38091754-A36128A4-B76B-4526-8C90-51F562337E86Q40187221-456B6681-7562-4BA5-973A-E0687F0E88C1Q41568932-653FEABA-9F60-42B7-BBFD-A0B32EA2250CQ41948797-072E2015-D76E-4A8B-A6C1-9D6E12329AAEQ42087174-0F26DC3A-8664-442A-998F-B6F02BED394FQ44489077-28AEB7BC-1B1C-4E98-802C-3F7A0FC18AECQ44754709-94677D3A-F351-495B-8436-EA945B1886EDQ44836010-018F4F1B-F42A-4D9C-89A8-181720936AF0Q46601898-969EE1A6-A5C2-43A1-ABA7-B6CA4B895DC5Q47801234-0095ADFE-6047-4210-93D2-4E249D9DE458Q47928015-2670A51F-19D6-4887-8194-A27194693D1DQ48298714-443228E8-4F5F-436C-AB9A-57F0F8082A52Q51707713-D05D14C3-1E3B-4500-99F4-110939A14033Q51770958-CBEAFF2E-E47B-4E63-A102-3AACB2500209Q56902718-A53497FF-EDF5-42EB-BCA8-41193081AC86Q58793936-8B75F020-E3C0-4B5F-8B53-A37267B3C514
P2860
Cellular and immunologic mechanisms in atopic dermatitis.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Cellular and immunologic mechanisms in atopic dermatitis.
@ast
Cellular and immunologic mechanisms in atopic dermatitis.
@en
Cellular and immunologic mechanisms in atopic dermatitis.
@nl
type
label
Cellular and immunologic mechanisms in atopic dermatitis.
@ast
Cellular and immunologic mechanisms in atopic dermatitis.
@en
Cellular and immunologic mechanisms in atopic dermatitis.
@nl
prefLabel
Cellular and immunologic mechanisms in atopic dermatitis.
@ast
Cellular and immunologic mechanisms in atopic dermatitis.
@en
Cellular and immunologic mechanisms in atopic dermatitis.
@nl
P356
P1476
Cellular and immunologic mechanisms in atopic dermatitis.
@en
P2093
P304
P356
10.1067/MJD.2001.109815
P407
P433
P577
2001-01-01T00:00:00Z